Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
The ruling in bankruptcy court caps a long legal battle over the fate of a company accused of fueling the opioid epidemic and the family that owns it.
“I got fevers, sweats, and I knew what was going on,” he said in a video on Instagram on Wednesday, after returning from a series of shows in Florida.
The agency that regulates drug safety has become too cozy with the industry it’s supposed to oversee.
The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter.
Clinical trials have repeatedly failed to show that the drug is effective against the virus. Still, U.S. demand is high.